Live healthier, stronger and sharper for longer
Short, frequent pieces on what changed in the science of ageing well — and our research library holds the deep dives.
PeptidesMOTS-c in the UK: 2026 Outlook for Availability
This deep dive examines the UK availability, legal standing, and cost considerations for MOTS-c, a promising mitochondrial-derived peptide, heading into 2026.
PeptidesMOTS-c for Healthspan After 50: 2026 Insights
Dive into MOTS-c, a mitochondrial peptide, and its implications for ageing adults. We explore benefits, risks, and practical considerations for those over 50.
PeptidesMOTS-c for Sleep: Optimising Your Rest by 2026
Investigate how MOTS-c, a mitochondrial-derived peptide, could reshape sleep quality and circadian health. Learn about its mechanisms, benefits, and optimal usage.
PeptidesMOTS-c for Women: Hormonal Harmony &
MOTS-c, a mitochondrial peptide, offers significant potential for women's health, addressing hormonal fluctuations, metabolic shifts, and age-related decline.
PeptidesMOTS-c Stacks for Longevity in 2026:
Discover how MOTS-c, a mitochondrial-derived peptide, can be synergistically stacked with other compounds to boost longevity efforts.
PeptidesMOTS-c Side Effects & Safety: A 2026
A deep dive into MOTS-c's safety, covering documented side effects, interactions, and essential monitoring for 2026 and beyond.
PeptidesMOTS-c Peptide: 2026 Evidence and Revised
New 2025-2026 clinical data reshapes our understanding of the MOTS-c peptide. We analyse the latest evidence, updating efficacy, safety, and usage recommendations.
PeptidesMOTS-c for Cognition & Focus: A 2026
Could the mitochondrial peptide MOTS-c be a key player in enhancing cognition and focus by 2026? We dissect the latest research.
PeptidesMOTS-c Dosing Protocols for Healthspan
Precision MOTS-c dosing is key for maximising its metabolic benefits. Understand clinically studied ranges, titration, and cycling strategies.
Wondering where to start?
Two minutes, no blood test, no sign-up — find out how you are actually ageing, and what to do about it.
The Sunday briefing
One email a week: what changed in the evidence, what it means for the markers you track, and the occasional thing worth stopping. No spam, unsubscribe anytime.